Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in honor of National Addiction Treatment Week (treataddictionsavelives.org).Claim CME for this episode at curbsiders.vcuhealth.org!By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | Free CME!CreditsProducers: Shawn Cohen MD,  Kenneth Morford MDWriter: Carolyn Chan MD MHSShow Notes: Shawn Cohen MDInfographic and Cover Art: Kenneth Morford MDHosts: Carolyn Chan MD. MHS Shawn Cohen MD, Natalie Stahl MD, Kenneth Morford MDReviewer: Kento Sonoda MDShowrunner: Carolyn Chan, MD, MHSTechnical Production: PodPasteGuest: Melissa Weimer DO MCRShow SegmentsIntro, disclaimer, guest bio Guest one-liner National Addiction Treatment Week  Case from Kashlak; Definitions Starting methadone  Common methadone pitfalls Buprenorphine precipitated opioid withdrawal  High-dose buprenorphine Treating buprenorphine precipitated withdrawal Low-dose buprenorphine Maintenance dose of buprenorphine ER buprenorphine Take home points